Neoantigens elicit T cell responses in breast cancer

Abstract Neoantigens are tumour-specific antigens that arise from non-synonymous mutations in tumour cells. However, their effect on immune responses in the tumour microenvironment remains unclear in breast cancer. We performed whole exome and RNA sequencing of 31 fresh breast cancer tissues and neo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Takafumi Morisaki, Makoto Kubo, Masayo Umebayashi, Poh Yin Yew, Sachiko Yoshimura, Jae-Hyun Park, Kazuma Kiyotani, Masaya Kai, Mai Yamada, Yoshinao Oda, Yusuke Nakamura, Takashi Morisaki, Masafumi Nakamura
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/2c8160b2daa6447d8caac1e64206aa46
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2c8160b2daa6447d8caac1e64206aa46
record_format dspace
spelling oai:doaj.org-article:2c8160b2daa6447d8caac1e64206aa462021-12-02T16:32:12ZNeoantigens elicit T cell responses in breast cancer10.1038/s41598-021-91358-12045-2322https://doaj.org/article/2c8160b2daa6447d8caac1e64206aa462021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-91358-1https://doaj.org/toc/2045-2322Abstract Neoantigens are tumour-specific antigens that arise from non-synonymous mutations in tumour cells. However, their effect on immune responses in the tumour microenvironment remains unclear in breast cancer. We performed whole exome and RNA sequencing of 31 fresh breast cancer tissues and neoantigen prediction from non-synonymous single nucleotide variants (nsSNVs) among exonic mutations. Neoantigen profiles were determined by predictive HLA binding affinity (IC50 < 500 nM) and mRNA expression with a read count of ≥ 1. We evaluated the association between neoantigen load and expression levels of immune-related genes. Moreover, using primary tumour cells established from pleural fluid of a breast cancer patient with carcinomatous pleurisy, we induced cytotoxic T lymphocytes (CTLs) by coculturing neoantigen peptide-pulsed dendritic cells (DCs) with autologous peripheral lymphocytes. The functions of CTLs were examined by cytotoxicity and IFN-γ ELISpot assays. Neoantigen load ranged from 6 to 440 (mean, 95) and was positively correlated to the total number of nsSNVs. Although no associations between neoantigen load and mRNA expression of T cell markers were observed, the coculture of neoantigen-pulsed DCs and lymphocytes successfully induced CTLs ex vivo. These results suggest that neoantigen analysis may have utility in developing strategies to elicit T cell responses.Takafumi MorisakiMakoto KuboMasayo UmebayashiPoh Yin YewSachiko YoshimuraJae-Hyun ParkKazuma KiyotaniMasaya KaiMai YamadaYoshinao OdaYusuke NakamuraTakashi MorisakiMasafumi NakamuraNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Takafumi Morisaki
Makoto Kubo
Masayo Umebayashi
Poh Yin Yew
Sachiko Yoshimura
Jae-Hyun Park
Kazuma Kiyotani
Masaya Kai
Mai Yamada
Yoshinao Oda
Yusuke Nakamura
Takashi Morisaki
Masafumi Nakamura
Neoantigens elicit T cell responses in breast cancer
description Abstract Neoantigens are tumour-specific antigens that arise from non-synonymous mutations in tumour cells. However, their effect on immune responses in the tumour microenvironment remains unclear in breast cancer. We performed whole exome and RNA sequencing of 31 fresh breast cancer tissues and neoantigen prediction from non-synonymous single nucleotide variants (nsSNVs) among exonic mutations. Neoantigen profiles were determined by predictive HLA binding affinity (IC50 < 500 nM) and mRNA expression with a read count of ≥ 1. We evaluated the association between neoantigen load and expression levels of immune-related genes. Moreover, using primary tumour cells established from pleural fluid of a breast cancer patient with carcinomatous pleurisy, we induced cytotoxic T lymphocytes (CTLs) by coculturing neoantigen peptide-pulsed dendritic cells (DCs) with autologous peripheral lymphocytes. The functions of CTLs were examined by cytotoxicity and IFN-γ ELISpot assays. Neoantigen load ranged from 6 to 440 (mean, 95) and was positively correlated to the total number of nsSNVs. Although no associations between neoantigen load and mRNA expression of T cell markers were observed, the coculture of neoantigen-pulsed DCs and lymphocytes successfully induced CTLs ex vivo. These results suggest that neoantigen analysis may have utility in developing strategies to elicit T cell responses.
format article
author Takafumi Morisaki
Makoto Kubo
Masayo Umebayashi
Poh Yin Yew
Sachiko Yoshimura
Jae-Hyun Park
Kazuma Kiyotani
Masaya Kai
Mai Yamada
Yoshinao Oda
Yusuke Nakamura
Takashi Morisaki
Masafumi Nakamura
author_facet Takafumi Morisaki
Makoto Kubo
Masayo Umebayashi
Poh Yin Yew
Sachiko Yoshimura
Jae-Hyun Park
Kazuma Kiyotani
Masaya Kai
Mai Yamada
Yoshinao Oda
Yusuke Nakamura
Takashi Morisaki
Masafumi Nakamura
author_sort Takafumi Morisaki
title Neoantigens elicit T cell responses in breast cancer
title_short Neoantigens elicit T cell responses in breast cancer
title_full Neoantigens elicit T cell responses in breast cancer
title_fullStr Neoantigens elicit T cell responses in breast cancer
title_full_unstemmed Neoantigens elicit T cell responses in breast cancer
title_sort neoantigens elicit t cell responses in breast cancer
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/2c8160b2daa6447d8caac1e64206aa46
work_keys_str_mv AT takafumimorisaki neoantigenselicittcellresponsesinbreastcancer
AT makotokubo neoantigenselicittcellresponsesinbreastcancer
AT masayoumebayashi neoantigenselicittcellresponsesinbreastcancer
AT pohyinyew neoantigenselicittcellresponsesinbreastcancer
AT sachikoyoshimura neoantigenselicittcellresponsesinbreastcancer
AT jaehyunpark neoantigenselicittcellresponsesinbreastcancer
AT kazumakiyotani neoantigenselicittcellresponsesinbreastcancer
AT masayakai neoantigenselicittcellresponsesinbreastcancer
AT maiyamada neoantigenselicittcellresponsesinbreastcancer
AT yoshinaooda neoantigenselicittcellresponsesinbreastcancer
AT yusukenakamura neoantigenselicittcellresponsesinbreastcancer
AT takashimorisaki neoantigenselicittcellresponsesinbreastcancer
AT masafuminakamura neoantigenselicittcellresponsesinbreastcancer
_version_ 1718383799723622400